bpc-157 sequence | C62H98N16O22 | CID 9941957 bpc-157 sequence gly-glu-pro-pro-pro-gly-lys-pro-ala-asp-asp-ala-gly-leu-val EP0983300B1 -

Please consult your physician before use if you are pregnant or nursing, under the age of 18, or are undergoing treatment for a medical condition

The mechanism aligns with BPC-157's gastric origins and makes biological sense

The 1mL option produces the highest concentration, which means very small draw volumes

8 weeks (0.251.0 mg/wk): ~1 vial 12 weeks (gradual to 1.7 mg/wk): ~2 vials 16 weeks (gradual to 2.44.5 mg/wk): ~3 vials Insulin Syringes (U-100, 1 mL) Per week: 1 syringe (once-weekly dosing) 12 weeks: 12 syringes 24 weeks: 24 syringes 48 weeks: 48 syringes Bacteriostatic Water (10 mL bottles) Use 2.0 mL (gradual) or 1.0 mL (advanced) per vial for reconstitution

However, studies have shown that it may be associated with weight loss in individuals with type 2 diabetes

Strength: 15 units per vial Dosage and administration: 0.15 ml (15 units) injected daily for 4-6 weeks, around the same time each day, on an empty stomach, preferably in the evening